Fabio Gallo Selected Research

Fabio Gallo Research Topics

Disease

6	Asthma (Bronchial Asthma) 11/2021 - 07/2017
3	Breast Neoplasms (Breast Cancer) 02/2021 - 12/2014
3	Inflammation (Inflammations) 01/2020 - 01/2011
3	Neoplasms (Cancer) 10/2015 - 11/2010
2	Hypertension (High Blood Pressure) 11/2021 - 01/2020
2	Hemorrhage 06/2020 - 01/2017
2	Multiple Sclerosis 01/2019 - 03/2016
2	Neuroblastoma 10/2012 - 01/2012
2	Rheumatoid Arthritis 01/2011 - 04/2010
1	Nasal Polyps (Nasal Polyp) 11/2021
1	Rhinitis 11/2021
1	Rhinosinusitis 11/2021
1	Periodontitis 06/2020
1	Chronic Periodontitis 06/2020
1	Hypersensitivity (Allergy) 01/2020
1	Bronchiectasis 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Osteoporosis 01/2020
1	Obstructive Sleep Apnea 01/2020
1	Pain (Aches) 07/2019
1	Acute Cholecystitis 07/2019
1	Postoperative Hemorrhage 07/2019
1	Urinary Incontinence 04/2019
1	Urethral Stricture 04/2019
1	Obesity 01/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Dermatitis Herpetiformis (Disease, Duhring's) 10/2018
1	Glioma (Gliomas) 11/2017
1	Allergic Rhinitis 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Anus Neoplasms (Anal Cancer) 10/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015
1	Neoplasm Metastasis (Metastasis) 10/2015
1	Acute Kidney Injury (Acute Renal Failure) 12/2014
1	Pathologic Complete Response 12/2014
1	Leukemia 02/2014
1	Genomic Instability 10/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2011
1	Stomach Neoplasms (Stomach Cancer) 11/2010

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 02/2021 - 01/2019
2	Aromatase InhibitorsIBA 02/2021 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2018 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2012
2	Prednisone (Sone)FDA LinkGeneric 01/2011 - 04/2010
2	Leflunomide (Arava)FDA LinkGeneric 01/2011 - 04/2010
1	SmokeIBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 06/2020
1	BradykininIBA 06/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020
1	phytobacteriomycin (PBM)IBA 06/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Bone Density Conservation AgentsIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	Immunoglobulin A (IgA)IBA 10/2018
1	AntibodiesIBA 10/2018
1	TransglutaminasesIBA 10/2018
1	Interleukin-17 (Interleukin 17)IBA 08/2017
1	CytokinesIBA 08/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Glatiramer Acetate (Copaxone)FDA Link 03/2016
1	InterferonsIBA 03/2016
1	Fluorouracil (Carac)FDA LinkGeneric 10/2015
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2015
1	CarcinogensIBA 02/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2012
1	HLA-G Antigens (HLA G)IBA 01/2012
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2012
1	RNA (Ribonucleic Acid)IBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010
1	ParaffinIBA 11/2010

Therapy/Procedure

5	Therapeutics 02/2021 - 01/2011
2	Contraindications 07/2019 - 01/2017
2	Radiotherapy 11/2017 - 10/2015
2	Drug Therapy (Chemotherapy) 10/2015 - 11/2010
1	Precision Medicine 11/2021
1	Low-Level Light Therapy (LLLT) 06/2020
1	Analgesia 07/2019
1	Operative Time 07/2019
1	Length of Stay 07/2019
1	Artificial Urinary Sphincter 04/2019
1	Critical Care (Surgical Intensive Care) 01/2017
1	Extracorporeal Membrane Oxygenation 01/2017
1	Salvage Therapy 01/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2015
1	Ischemic Postconditioning 12/2014
1	Neoadjuvant Therapy 12/2014